Cited 17 time in webofscience Cited 15 time in scopus

Rho-kinase/AMPK axis regulates hepatic lipogenesis during overnutrition

Title
Rho-kinase/AMPK axis regulates hepatic lipogenesis during overnutrition
Authors
Huang, HuLee, Seung-HwanSousa-Lima, InesKim, Sang SooHwang, Won MinDagon, YossiYang, Won-MoCho, SungmanKang, Min-CheolSeo, Ji A.Shibata, MunehikoCho, HyunsooBelew, Getachew DebasBhin, JinhyukDesai, Bhavna N.Ryu, Min JeongShong, MinhoLi, PeixinMeng, HuaChung, Byung-HongHwang, DaeheeKim, Min SeonPark, Kyong SooMacedo, Maria PaulaWhite, MorrisJones, JohnKim, Young-Bum
DGIST Authors
Hwang, Daehee
Issue Date
2018-12
Citation
Journal of Clinical Investigation, 128(12), 5335-5350
Type
Article
Article Type
Article
ISSN
0021-9738
Abstract
Obesity is a major risk factor for developing nonalcoholic fatty liver disease (NAFLD). NAFLD is the most common form of chronic liver disease and is closely associated with insulin resistance, ultimately leading to cirrhosis and hepatocellular carcinoma. However, knowledge of the intracellular regulators of obesity-linked fatty liver disease remains incomplete. Here we showed that hepatic Rho-kinase 1 (ROCK1) drives obesity-induced steatosis in mice through stimulation of de novo lipogenesis. Mice lacking ROCK1 in the liver were resistant to diet-induced obesity owing to increased energy expenditure and thermogenic gene expression. Constitutive expression of hepatic ROCK1 was sufficient to promote adiposity, insulin resistance, and hepatic lipid accumulation in mice fed a high-fat diet. Correspondingly, liver-specific ROCK1 deletion prevented the development of severe hepatic steatosis and reduced hyperglycemia in obese diabetic (ob/ob) mice. Of pathophysiological significance, hepatic ROCK1 was markedly upregulated in humans with fatty liver disease and correlated with risk factors clustering around NAFLD and insulin resistance. Mechanistically, we found that hepatic ROCK1 suppresses AMPK activity and a ROCK1/AMPK pathway is necessary to mediate cannabinoid-induced lipogenesis in the liver. Furthermore, treatment with metformin, the most widely used antidiabetes drug, reduced hepatic lipid accumulation by inactivating ROCK1, resulting in activation of AMPK downstream signaling. Taken together, our findings establish a ROCK1/AMPK signaling axis that regulates de novo lipogenesis, providing a unique target for treating obesity-related metabolic disorders such as NAFLD. Copyright 2018, American Society for Clinical Investigation.
URI
http://hdl.handle.net/20.500.11750/9512
DOI
10.1172/JCI63562
Publisher
American Society for Clinical Investigation
Files:
There are no files associated with this item.
Collection:
Department of New BiologySystems Biology and Medicine Lab1. Journal Articles


qrcode mendeley

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

BROWSE